Delivery Order SPE2DB20D1051-SPE2DB24FD7FT

Award Date 3/6/24
Potential Completion Date 3/7/24
Potential Value $1.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $7,753.45 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide 4,563,449,408 units of Methylphenidate ER 18 mg tablets. The delivery order has a completion date of January 26, 2024 and was awarded on January 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA, which serves as the primary contract vehicle for...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,512,599 units of Methylphenidate ER 18 mg tablets in 100-count bottles. The $1,263.10 contract has a completion date of February 2, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which falls under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price Delivery Order by the Defense Logistics Agency (DLA) to provide 4,563,880,810 units of Methylphenidate ER 18 MG Tablets in 100 count bottles. The contract has a potential value of $1,797.61 and a completion date of March 6, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 through December...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 4,563,767,616 methylphenidate ER 36 mg tablets in packages of 100. The contract has a potential value of $1,936.68 and a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 4,563,546,088 units of Methylphenidate ER 36 MG tablets in 100-count packages. The contract has a potential value of $3,903.50 and a completion date of February 6, 2024. This delivery order contract is issued under an Indefinite Delivery Contract (IDC) with a potential value of up to $999,999,999.00 and a...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to provide 4563548363 - Methylphenidate ER 27 mg tablets in 100-count packages. The contract has a potential value of $1,288.75 and a completion date of February 6, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,731,300 units of Methylphenidate ER 18 mg tablets. The contract, valued at $1,894.65, has a completion date of February 22, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is responsible for delivering the pharmaceutical products to the agency. This award is...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,873,177 units of Methylphenidate ER 54 mg tablets in 100-count bottles. The contract has a total potential value of $1,371.80 and a completion date of March 7, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide Methylphenidate ER 36 mg tablets. The potential value of the contract is $1,294.97, with a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a period...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,096,123 units of methylphenidate ER 18 mg tablets in 100-count bottles. The contract has a ceiling value of $8,140.56 and a period of performance through March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. This...
  • SPE2DB20D1051
    Indefinite Delivery Contract
  • SPE2DB20D1051-SPE2DB24FD7FT
    Delivery Order

Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 4,563,881,105 units of Methylphenidate ER 18 mg tablets in 100-count bottles. The $1,316.99 award has a completion date of March 7, 2024 and does not utilize any set-aside designations. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.

Generated 6/5/24, 10:02 AM